Abstract
Background —A deficiency of muscle LIM protein results in dilated cardiomyopathy, but the function of other LIM proteins in the heart has not been assessed previously. We have characterized the expression and function of FHL2, a heart-specific member of the LIM domain gene family. Methods and Results —Expression of FHL2 mRNA and protein was examined by Northern blot, in situ hybridization, and Western blot analyses of fetal and adult mice. FHL2 transcripts are present at embryonic day (E) 7.5 within the cardiac crescent in a pattern that resembles that of Nkx2.5 mRNA. During later stages of cardiac development and in adult animals, FHL2 expression is localized to the myocardium and absent from endocardium, cardiac cushion, outflow tract, or coronary vasculature. The gene encoding FHL2 was disrupted by homologous recombination, and knockout mice devoid of FHL2 were found to undergo normal cardiovascular development. In the absence of FHL2, however, cardiac hypertrophy resulting from chronic infusion of isoproterenol is exaggerated (59% versus 20% increase in heart weight/body weight in FHL null versus wild-type mice; P <0.01). Conclusions —FHL2 is an early marker of cardiogenic cells and a cardiac-specific LIM protein in the adult. FHL2 is not required for normal cardiac development but modifies the hypertrophic response to β-adrenergic stimulation.
References
33
Referenced
123
- Jurata LW, Gill GN. Structure and function of LIM domains. Curr Top Microbiol Immunol. 1998;228:75–113. / Curr Top Microbiol Immunol (1998)
10.1016/S0925-4773(99)00314-7
10.1038/374425a0
10.1126/science.278.5344.1809
10.1016/S0092-8674(00)80985-X
10.1016/0092-8674(94)90192-9
10.1128/MCB.17.8.4750
10.1016/S0092-8674(00)81878-4
10.1089/dna.1997.16.433
10.1006/dbio.1997.8657
10.1128/MCB.17.9.5236
10.1042/bj3450335
10.1242/dev.126.4.839
10.1002/(SICI)1520-6408(1996)19:2<146::AID-DVG6>3.0.CO;2-9
10.1016/S0022-2275(20)32400-7
10.1006/bbrc.1996.1222
10.1016/S0378-1119(97)00644-6
10.1006/bbrc.1999.0179
10.1006/jmcc.1998.0922
10.1242/dev.119.2.419
10.1073/pnas.90.17.8145
10.1242/dev.126.7.1439
10.1242/dev.125.22.4461
10.1242/dev.126.1.75
10.1006/jmcc.1997.0508
10.1161/res.83.10.980
10.1016/S0925-4773(00)00341-5
10.1074/jbc.274.38.27083
10.1016/S0378-1119(99)00125-0
10.1006/bbrc.1999.0179
10.1038/18237
10.1093/emboj/19.3.359
10.1172/JCI2950
Dates
Type | When |
---|---|
Created | 13 years, 2 months ago (June 11, 2012, 8:09 p.m.) |
Deposited | 1 year, 3 months ago (May 12, 2024, 8:58 a.m.) |
Indexed | 1 week, 4 days ago (Aug. 19, 2025, 6:07 a.m.) |
Issued | 24 years, 2 months ago (June 5, 2001) |
Published | 24 years, 2 months ago (June 5, 2001) |
Published Print | 24 years, 2 months ago (June 5, 2001) |
@article{Kong_2001, title={Cardiac-Specific LIM Protein FHL2 Modifies the Hypertrophic Response to β-Adrenergic Stimulation}, volume={103}, ISSN={1524-4539}, url={http://dx.doi.org/10.1161/01.cir.103.22.2731}, DOI={10.1161/01.cir.103.22.2731}, number={22}, journal={Circulation}, publisher={Ovid Technologies (Wolters Kluwer Health)}, author={Kong, Yanfeng and Shelton, John M. and Rothermel, Beverly and Li, Xiangqing and Richardson, James A. and Bassel-Duby, Rhonda and Williams, R. Sanders}, year={2001}, month=jun, pages={2731–2738} }